University of Ulm clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 143 studies whose lead sponsor is University of Ulm. 25 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 16, 2026.
Keep track of what changes. Save the University of Ulm studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions University of Ulm leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 143. Browse all 143 →
- Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2RecruitingNCT04628026Phase 3
- Glucose-Level During Endurance ExerciseRecruitingNCT07543705
- Hypercaloric PEG Nutrition in ALS to Sustain Energy HomeostasisRecruitingNCT06877143Not applicable
- Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RecruitingNCT04881682Phase 2
- Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)RecruitingNCT04871035
- Imprinting in Metabolic Diseases - Identifying Epigenetic Mechanisms in Human Gestational Diabetes Through Cell-free DNARecruitingNCT07436195
- The Importance of Insulin Action in the Brain for the Immune System During Physical Activity-OverweightNot yet recruitingNCT07466173Not applicable
- Magnetic Resonance Imaging in Metabolic DiseasesRecruitingNCT06709846
- Impact of Thyroid Hormones on Human Glucose and Energy MetabolismRecruitingNCT07410637Not applicable
- Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - The Biology and Outcome (BiO)-ProjectRecruitingNCT01252485
- International Genetic Obesity RegistryRecruitingNCT07296900
- Registry for Patients With LipodystrophyRecruitingNCT03553420
- Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RecruitingNCT07154524
- Understanding Individual Variability in Neuronal Signal Transmission to Target Organs in Health and DiseaseRecruitingNCT06912048Not applicable
- Texture and Color Enhancement Imaging (TXI) for Inflammation Assessment in Patients With Inflammatory Bowel DiseasesRecruitingNCT06892990Not applicable
- Fertility Protection for Children, Adolescents and Young AdultsRecruitingNCT06692868
- Hilotherapy for Prevention of Chemotherapy-induced Peripheral PolyneuropathyRecruitingNCT06627348Not applicable
- Immune Modulation by Exosomes in COVID-19RecruitingNCT05191381
- Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa SepsisRecruitingNCT03044223
- Hemophagocytosis in Critically Ill Adult PatientsRecruitingNCT01913938
- Burden, Mortality and Supply Costs in Intensive Care Unit PatientsRecruitingNCT04094428
- Evaluation of 3D Ultrasound in Brain Tumor SurgeryRecruitingNCT05956977Not applicable
- German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)RecruitingNCT03125707
- Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade GliomasRecruitingNCT02686229
- PACAREG: a Multicenter Registry Trial in Pancreatic Ductal AdencarcinomaRecruitingNCT04099134
- Ultra-high-caloric, Fatty Diet in ALSActive, not recruitingNCT06280079Not applicable
- Efficacy and Tolerability of Beta Hydroxybutyrate Ester in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT04820478Not applicable
- Pembrolizumab in MarginalzoneLymphoma A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDYTerminatedNCT04268277Phase 2
- Relative Contribution of Brain Insulin Action for Postprandial MetabolismActive, not recruitingNCT06295640Not applicable
- Relevance of Reactive Hypoglycemia During an OGTT in Everyday Life Using Continuous Glucose MeasurementCompletedNCT06182527Not applicable
- The Importance of Insulin Action in the Brain for the Immune System During Physical ActivityActive, not recruitingNCT06552130Not applicable
- Physiological Reaction After Food IntakeActive, not recruitingNCT06548165Not applicable
- Whey Protein Pre-load and Postprandial Glycemia in PregnancyCompletedNCT06170905Not applicable
- Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse GeneticsActive, not recruitingNCT03897127Phase 3
- Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MFCompletedNCT01644110Phase 1/2
- NT-proBNP in ICU Postoperative/Posttraumatic Patients With ShockCompletedNCT00736723
- Honest, Open, Proud for Soldiers with Mental IllnessCompletedNCT03218748Not applicable
- CD64 and Antibiotics in Human SepsisCompletedNCT02922998
- Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's MacroglobulinemiaCompletedNCT01788020Phase 3
- Economic Aspects of Extreme Obesity in AdolescentCompletedNCT01632098
- Randomized Phase III Study of Intensive Chemotherapy With or Without Dasatinib (Sprycel™)CompletedNCT02013648Phase 3
- Transcutaneous Carbon-dioxide Monitoring in Electrophysiological Procedures in Deep SedationActive, not recruitingNCT04038476Not applicable
- Critically Ill ICU Patients Under Casirivimab- and/or Tocilizumab ApplicationCompletedNCT06233357
- Reducing Pacemaker Implantation After TAVR With Modified Implantation TechniqueCompletedNCT04734392
- Efficiency and Safety of Nasal Positive Airway Pressure Systems During EndoscopyCompletedNCT05972304Not applicable
- Endocrine Outcome of Surgery for Pituitary AdenomaTerminatedNCT03515603Not applicable
- Determination of Immune Phenotype in Glioblastoma PatientsCompletedNCT02751138
- Study of Chemotherapy in Combination With All-trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene MutationCompletedNCT00893399Phase 3
- Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLLCompletedNCT02758665Phase 2
- Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 MutationsTerminatedNCT02298166Phase 3